Forget, PatriceAguirre, Jose ABencic, IvankaBorgeat, AlainCama, AllessandroCondron, ClaireEintrei, ChristinaEroles, PilarGupta, AnilHales, Tim GIonescu, DanielaJohnson, MarkKabata, PawelKirac, IvaMa, DaqingMokini, ZhirajrGuerrero Orriach, Jose LuisRetsky, MichaelSandrucci, SergioSiekmann, WiebkeŠtefančić, LjiljaVotta-Vellis, GinaConnolly, CaraBuggy, Donal2024-02-102024-02-102019-04-282072-6694http://hdl.handle.net/10668/13891http://hdl.handle.net/20.500.12105/17860The question of whether anesthetic, analgesic or other perioperative intervention during cancer resection surgery might influence long-term oncologic outcomes has generated much attention over the past 13 years. A wealth of experimental and observational clinical data have been published, but the results of prospective, randomized clinical trials are awaited. The European Union supports a pan-European network of researchers, clinicians and industry partners engaged in this question (COST Action 15204: Euro-Periscope). In this narrative review, members of the Euro-Periscope network briefly summarize the current state of evidence pertaining to the potential effects of the most commonly deployed anesthetic and analgesic techniques and other non-surgical interventions during cancer resection surgery on tumor recurrence or metastasis.engVoRhttp://creativecommons.org/licenses/by/4.0/AnalgesiaAnesthesiaCancerAttribution 4.0 International3103532111510.3390/cancers11050592Cancersopen access